IP Library › Assignment 052256/0505
Patent Assignment
Reel/Frame 052256/0505

Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 52232 Frame: 118. Assignor(S) Hereby Confirms the Assignment.

Recorded: 2020-03-30 Pages: 9
Assignors
LIAO, X. CHARLENE
Executed: 2018-07-05
LIU, QIAN
Executed: 2018-07-05
Assignee
IMMUNE-ONC THERAPEUTICS, INC.
4030 FABIAN WAY, PALO ALTO, CALIFORNIA, 94303
Covered Property (1)
Anti-Leukocyte-Associated Immunoglobulin-Like Receptor 1 (LAIR1) Monoclonal Antibodies and Method of Use Thereof to Treat Cancer
Application: 16/475,223 →
Publication: US 2019/0338026
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 26, 2020
From: LIAO, X. CHARLENE; LIU, QIANG
To: IMMUNE-ONE THERAPEUTICS, INC.
Reel/Frame 052232/0118 →
Assignment of Assignor's Interest Mar 26, 2020
From: IMMUNE-ONE THERAPEUTICS, INC.; AN, ZHIQIANG; ZHANG, NINGYAN; GUI, XUN
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 052232/0603 →
Corrective Assignment to Correct the Conveying Party Data. Previously Recorded at Reel: 052232 Frame: 0603. Assignor(S) Hereby Confirms the Assignment. Mar 30, 2020
From: IMMUNE-ONC THERAPEUTICS, INC.; AN, ZHIQIANG; ZHANG, NINGYAN; GUI, XUN
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 052258/0520 →